Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.
BACKGROUND
Plasmodium falciparum merozoite surface protein-1 (MSP1) has been extensively studied as a blood-stage malaria vaccine candidate, with most work focused on the conserved 19 kDa and semi-conserved 42 kDa C-terminal regions (blocks 16-17) and the hypervariable N-terminal repeat region (block 2). However, recent genotyping studies suggest that additional regions of MSP1 may be under selective pressure, including a locus of intragenic recombination designated as block 4 within the 3' region of the gene.


METHODS
The current study examined the antibody response to the two parental and two recombinant forms of block 4 and to blocks 16-17 (3D7) in study populations from Colombia, Papua New Guinea and Cameroon that differ in malaria transmission intensity and ethnic composition.


RESULTS
IgM and IgG antibodies were detected against parental and recombinant MSP1 block 4 peptides in all three populations. Overall, 32-44% of the individuals produced IgM to one or more of the peptides, with most individuals having IgM antibodies reactive with both parental and recombinant forms. In contrast, IgG seropositivity to block 4 varied among populations (range 15-65%), with the majority of antibodies showing specificity for one or a pair of block 4 peptides. The IgG response to block 4 was significantly lower than that to blocks 16-17, indicating block 4 is subdominant. Antibodies to block 4 and blocks 16-17 displayed distinct IgG subclass biases, with block 4 responses biased toward IgG3 and blocks 16-17 toward IgG1. These patterns of responsiveness were consistently observed in the three study populations.


CONCLUSIONS
Production of antibodies specific for each parental and recombinant MSP1 block 4 allele in different populations exposed to P. falciparum is consistent with balancing selection of the MSP1 block 4 region by the immune response of individuals in areas of both low and high malaria transmission. MSP1 block 4 determinants may be important in isolate-specific immunity to P. falciparum.
Chang
Sandra P
SP
John A Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo St, Honolulu, HI 96813, USA. sandrac@hawaii.edu
Kayatani
Alexander K K
AK
Terrientes
Zilka I
ZI
Herrera
Socrates
S
Leke
Rose G F
RG
Taylor
Diane W
DW
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D000913:Antibodies, Protozoan / Q000235:genetics / Q000276:immunology; D002163:Cameroon; D002648:Child; D002675:Child, Preschool; D003105:Colombia; D003429:Cross Reactions / Q000235:genetics / Q000276:immunology; D000939:Epitopes / Q000235:genetics / Q000276:immunology*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007074:Immunoglobulin G / Q000235:genetics / Q000276:immunology*; D007075:Immunoglobulin M / Q000235:genetics / Q000276:immunology*; D007223:Infant; D016778:Malaria, Falciparum / Q000276:immunology* / Q000635:transmission; D008297:Male; D020066:Merozoite Surface Protein 1 / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D008875:Middle Aged; D010219:Papua New Guinea; D010963:Plasmodium falciparum / Q000235:genetics / Q000276:immunology*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology; D055815:Young Adult
D000913:Antibodies, Protozoan; D000939:Epitopes; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D020066:Merozoite Surface Protein 1; D011994:Recombinant Proteins